TIS tissue therapies limited

stalling tactics, page-3

  1. 4,014 Posts.
    lightbulb Created with Sketch. 2069
    As frustrating as the process of obtaining the CE Mark seems to be, I'm now more concerned with our partners progress on ensuring the sales and supply channels are in place. Not only is that approval process well within the control of TIS and it's partners, it is also a measure of how serious Quintiles are about selling the product.

    This deadline is looming and both deliverables/milestones will be on the critical path before too long.

    That said, it doesn't seem to matter what industry it is, delays always seem to be the norm.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.